Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and E streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Search jobs 24-May-2021 Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3
DGAP-News: ABIVAX / Key word(s): Study results
24.05.2021 / 18:30
The issuer is solely responsible for the content of this announcement.
Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis
and plans to proceed to phase 3
Primary endpoint (statistically significant reduction of Modified Mayo Score
[1]) was met with once-daily ABX464 (25mg, 50mg, 100mg) at week 8 in these 254 patients randomized, double-blind and placebo-controlled clinical trial (p
DGAP-News: ABIVAX: Abivax gibt hervorragende Ergebnisse der Phase-2b-Studie zur Wirksamkeit und Sicherheit von ABX464 in Colitis ulcerosa bekannt und plant Start der Phase 3 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.